PharmD Info

A forum for Indian Pharmacy Professionals

Phases of Clinical Trials, Preclinical and Clinical Phase 1, Phase 2, Phase 3, and Phase 4 Studies.Vaccine, FDA, NIDA Clinical Trials.
Forum rules: General rules are applicable for this forum- Find Here
  • User avatar
Ministry of Health and Family Welfare (MoHFW), India - New Drugs and Clinical Trials (Third Amendment) Rules, 2022

The Department of Health and Family Welfare vide notification dated 14th October, 2022 has issued the New Drugs and Clinical Trials (Third Amendment) Rules, 2022.

The amendment provides that when an application for registration of ethics committee for clinical trials is submitted and where no communication has been received from the Central Licensing Authority within the period of forty-five working days, the registration of Ethics Committee shall be deemed to have been granted by the Central Licensing Authority.

The registration shall be deemed to be legally valid for all purposes and the applicant shall be authorized to initiate clinical trial in accordance with the rules.

Download - NDCT 2022 Amendment
(1.19 MiB) Downloaded 314 times
Similar Topics
Topics Statistics Last post
0 Replies 
by Admin
0 Replies 
by sumii683
0 Replies 
by sumii683
0 Replies 
by sumii683
0 Replies 
by raghusingh

Embarking on a profession in pharmacy involves no […]

Tamoxifen remains active for up to two weeks after[…]

Pharmacy practice in India is a dynamic and rapidl[…]

PBMs, or Pharmacy Benefit Managers, are businesses[…]

PharmD Info - Highlights